[en] The intestinal microbiota is the largest source of microbial stimulation that exerts both harmful and beneficial effects on human health. The interaction between probiotic and enterocytes is the initiating event in immunomodulation and merits particular attention. The effects of probiotic is strain dependent and for each new probiotic strain, profiles of cytokines secreted by lymphocytes, enterocytes or dendritic cells that come in contact with the strain should be systematically established. To evaluate the effects of probiotics on the immune system, models that mimic the mucosa, and thus the physiological reality, should be preferred whenever it is possible. Then, the in vitro observed effects should be backed up by properly conducted randomized double bind clinical studies. More detailed studies are needed to determine the precise action mode of probiotics on both mucosal and systemic immunity.
Disciplines :
Microbiology
Author, co-author :
Delcenserie, Véronique ; Université Laval > Département de sciences des aliments et de nutrition > Institut des Nutraceutiques et des Aliments Fonctionnels (INAF)
Martel, D.
Lamoureux, M.
Amiot, J.
Boutin, Y.
Roy, D.
Language :
English
Title :
Immunomodulatory effects of probiotics in the intestinal tract.
Amrouche, T., Boutin, Y., Prioult, G., Fliss, I. (2006). Effects of bifidobacterial cytoplasm, cell wall and exopolysaccharide on mouse lymphocyte proliferation and cytokine production. Inter Dairy J 16, 70-80.
Arunachalam, K., Gill, H.S., and Chandra, R.K. (2000). Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr 54, 263-267.
Baharav, E., Mor, F., Halpem, M., and Weinberger, A. (2004). Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J Nutr 134, 1964-1969.
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L., and Kuchroo, V.K. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238.
Bibiloni, R., Fedorak, R.N., Tannock, G.W., Madsen, K.L., Gionchetti, P., Campieri, M., De Simone, C., and Sartor, R.B. (2005). VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100, 1539-1546.
Borody, T.J., Warren, E.F., Leis, S.M., Surace, R., Ashman, O., and Siarakas, S, (2004). Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 38, 475-483.
Borruel, N., Carol, M., Casellas, F, Antolin, M., de Lara, F., Espin, E., Naval, J., Guarner, F., and Malagelada, J.R. (2002). Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 51, 659-664.
Braat, H., van den Brande, J., van Tol, E., Hommes, D., Peppelenbosch, M., and van Deventer, S. (2004). Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am J Clin Nutr 80, 1618-1625.
Butler, D.M., Malfait, A.M., Maini, R.N., Brennan, F.M., and Feldmann, M. (1999). Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis. Eur J Immunol 29, 2205-2212.
Carol, M., Borruel, N., Antolin, M., Llopis, M., Casellas, F., Guarner, F., and Malagelada, J.R. (2006). Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease. J Leukoc Biol 79, 917-922.
Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A., and Weiner, H.L. (1994). Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240.
Christensen, H.R., Frokiaer, H., and Pestka, J.J. (2002). Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 168, 171-178.
Claassen, E., Van Winsen, R., Posno, M., and Boersma, W.J. (1995). New and safe "oral" live vaccines based on lactobacillus. Adv Exp Med Biol 371B, 1553-1558.
Cross, M.L., Mortensen, R.R., Kudsk, J., and Gill, H.S. (2002). Dietary intake of Lactobacillus rhamnosus HNOO1 enhances production of both Th1 and Th2 cytokines in antigen-primed mice. Med Microbiol Immunol 191, 49-53.
Cummings, J.H., Antoine, J.M., Azpiroz, F., Bourdet-Sicard, R., Brandtzaeg, P., Calder, P.C., Gibson, G.R., Guarner, F., Isolauri, E., Pannemans, D., et al. (2004). PASSCLAIM - gut health and immunity. Eur J Nutr 43 Suppl 2, 11118-11173.
de Waard, R., Claassen, E., Bokken, G.C., Buiting, B., Garssen, J., and Vos, J.G. (2003). Enhanced immunological memory responses to Listeria monocytogenes in rodents, as measured by delayed-type hypersensitivity (DTH), adoptive transfer of DTH, arld protective immunity, following Lactobacillus casei Shirota ingestion. Clin Diagn Lab Immunol 10, 59-65.
Delneste, Y., Donnet-Hughes, A., and Schiffrin, E.J. (1998). Functional foods: mechanisms of action on immunocompetent cells. Nutr Rev 56, S93-98.
Delves, P.J., and Roitt, I.M. (2000). The immune system. First of two parts. N Engl J Med 343, 37-49.
Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W., and Boirivant, M. (2005). Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174, 3237-3246.
Donnet-Hughes, A., Rochat, F., Serrant, P., Aeschlimann, J.M., and Schiffrin, E.J. (1999). Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. J Dairy Sci 82, 863-869.
Drakes, M., Blanchard, T., and Czinn, S. (2004). Bacterial probiotic modulation of dendritic cells. Infect Immun 72, 3299-3309.
Duchmann, R., Kaiser, I., Hermann, E., Mayet, W., Ewe, K., and Meyer zum Buschenfelde, K.H. (1995). Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102, 448-455.
Fukushima, Y., Kawata, Y., Hara, H., Terada, A., and Mitsuoka, T. (1998). Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 42, 39-44.
Galdeano, C.M., and Perdigon, G. (2004). Role of viability of probiotic strains in their persistenoe in the gut and in mucosal immune stimulation. J Appl Microbiol 97, 673-681.
Gill, H.S., Rutherfurd, K.J., and Cross, M.L. (2001a). Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 21, 264-271.
Gill, H.S., Rutherfurd, K.J., Cross, M.L., and Gopal, P.K. (2001b). Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74, 833-839.
Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K.M., Brigidi, P., Vitali, B., Poggioli, G., Miglioli, M., and Campieri, M. (2003). Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124, 1202-1209.
Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., and Campieri, M. (2000). Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119, 305-309.
Gosselink, M.P., Schouten, W.R., van Lieshout, L.M., Hop, W.C., Laman, J.D., and Ruseler-van Embden, J.G. (2004). Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis Colon Rectum 47, 876-884.
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J.E., and Roncarolo, M.G. (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742.
Gupta, P., Andrew, H., Kirschner, B.S., and Guandalini, S. (2000). Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 31, 453-457.
Guslandi, M., Mezzi, G., Sorghi, M., and Testoni, P.A. (2000). Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 45, 1462-1464.
Haller, D., Bode, C., Hammes, W.P., Pfeifer, A.M., Schiffrin, E.J., and Blum, S. (2000). Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47, 79-87.
Harrington, L.E., Mangan, P.R., and Weaver, C.T. (2006). Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18, 349-356.
Hart, A.L., Lammers, K., Brigidi, P., Vitali, B., Rizzello, F., Gionchetti, P., Campieri, M., Kamm, M.A., Knight, S.C., and Stagg, A.J. (2004). Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53, 1602-1609.
Hatakka, K., Martio, J., Korpela, M., Herranen, M., Poussa, T., Laasanen, T., Saxelin, M., Vapaatalo, H., Moilanen, E., and Korpela, R. (2003). Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis-a pilot study. Scand J Rheumatol 32, 211-215.
Helin, T., Haahtela, S., and Haahtela, T. (2002). No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 57, 243-246.
Ibnou-Zekri, N., Blum, S., Schiffrin, E.J., and von der Weid, T. (2003). Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 71, 428-436.
Isolauri, E., Arvola, T., Sutas, Y., Moilanen, E., and Salminen, S. (2000). Probiotics in the management of atopic eczema. Clin Exp Allergy 30, 1604-1610.
Isolauri, E., Joensuu, J., Suomalainen, H., Luomala, M., and Vesikari, T. (1995). Improved immunogenicity of oral D × RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13, 310-312.
Kaila, M., Isolauri, E., Saxelin, M., Arvilommi, H., and Vesikari, T. (1995). Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 72, 51-53.
Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., and Isolauri, E. (2001). Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076-1079.
Kalliomaki, M., Salminen, S., Poussa, T., Arvilommi, H., and Isolauri, E. (2003). Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361, 1869-1871.
Kato, I., Endo-Tanaka, K., and Yokokura, T. (1998). Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sci 63, 635-644.
Kato, K., Mizuno, S., Umesaki, Y., Ishii, Y., Sugitani, M., Imaoka, A., Otsuka, M., Hasunuma, O., Kurihara, R., Iwasaki, A., et al. (2004). Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther 20, 1133-1141.
Kishi, A., Uno, K., Matsubara, Y., Okuda, C., and Kishida, T. (1996). Effect of the oral administration of Lactobacillus brevis subsp. coagulans on interferon-alpha producing capacity in humans. J Am Coll Nutr 15, 408-412.
Korzenik, J.R., and Podolsky, D.K. (2006). Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov 5, 197-209.
Kruis, W., Fric, P., Pokrotnieks, J., Lukas, M., Fixa, B., Kascak, M., Kamm, M.A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004). Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53, 1617-1623.
Kruis, W., Schutz, E., Fric, P., Fixa, B., Judmaier, G., and Stolte, M. (1997). Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11, 853-858.
Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. (1993). Intedeukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
Kukkonen, K., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T., and Kuitunen, M. (2007). Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial, J Allergy Clin Immunol 119, 192-198.
Lammers, K.M., Helwig, U., Swennen, E., Rizzello, F., Venturi, A., Caramelli, E., Kamm, M.A., Brigidi, P., Gionchetti, P., and Campieri, M. (2002). Effect of probiotic strains on interleukin 8 production by HT29/ 19A cells. Am J Gastroenterol 97, 1182-1186.
Leblanc, J., Fliss, I., and Matar, C. (2004). Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk. Clin Diagn Lab Immunol 11, 1171-1181.
Lefrancois, L., and Puddington, L. (2006). Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. Annu Rev Immunol 24, 681-704.
Leonard, W.J. (2003). Type I cytokines and interferons and their receptors. In Fundamental Immunology (W. E. Paul, ed) Lippincott Williams & Wilkins, Philadelphia 701-747.
Link-Amster, H., Rochat, F., Saudan, K.Y., Mignot, O., and Aeschlimann, J.M. (1994). Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 10, 55-63.
Ma, D., Forsythe, P., and Bienenstock, J. (2004). Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 72, 5308-5314.
Maassen, C.B., van Holten, J.C., Balk, F., Heijne den Bak-Glashouwer, M.J., Leer, R., Laman, J.D., Boersma, W.J., and Claassen, E. (1998). Orally administered Lactobacillus strains differentially affect the direction and efficacy of the immune response. Vet Q 20 Suppl 3, S81-83.
Maassen, C.B., van Holten-Neelen, C., Balk, F., den Bak-Glashouwer, M.J., Leer, R.J., Laman, J.D., Boersma, W.J., and Claassen, E. (2000). Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18, 2613-2623.
Macdonald, T.T., and Monteleone, G. (2005). Immunity, inflammation, and allergy in the gut. Science 307, 1920-1925.
MacDonald, T.T., Monteleone, G., and Pender, S.L. (2000). Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 51, 2-9.
Madsen, K.L., Doyle, J.S., Jewell, L.D., Tavernini, M.M., and Fedorak, R.N. (1999). Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 1107-1114.
Majamaa, H., and Isolauri, E. (1997). Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 99, 179-185.
Majamaa, H., Isolauri, E., Saxelin, M., and Vesikari, T. (1995). Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 20, 333-338.
Matsuzaki, T., Nagata, Y., Kado, S., Uchida, K., Kato, I., Hashimoto, S., and Yokokura, T. (1997). Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. Apmis 105, 643-649.
Matsuzaki, T., Yamazaki, R., Hashimoto, S., and Yokokura, T. (1998). The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J Dairy Sci 81, 48-53.
McCarthy, J., O'Mahony, L., O'Callaghan, L., Sheil, B., Vaughan, E.E., Fitzsimons, N., Fitzgibbon, J., O'Sullivan, G.C., Kiely, B., Collins, J.K., et al. (2003). Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52, 975-980.
Mestecky, J., Blumberg, R.S., Kiyono, H., McGhee, J.R. (2003). The mucosal immune system. In Fundamental Immunology (W. E. Paul, ed) Lippincott Williams & Wilkins, Philadelphia 965-1021.
Miettinen, M., Matikainen, S., Vuopio-Varkila, J., Pirhonen, J., Varkila, K., Kurimoto, M., and Julkunen, I. (1998). Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun 66, 6058-6062.
Miettinen, M., Vuopio-Varkila, J., and Varkila, K. (1996). Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 64, 5403-5405.
Mimura, T., Rizzello, F., Helwig, U., Poggioli, G., Schreiber, S., Talbot, I.C., Nicholls, R.J., Gionchetti, P., Campieri, M., and Kamm, M.A. (2004). Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53, 108-114.
Mohamadzadeh, M., Olson, S., Kalina, W.V., Ruthel, G., Demmin, G.L., Warfield, K.L., Bavari, S., and Klaenhammer, T.R. (2005). Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A 102, 2880-2885.
Moore, K.W., de Waal Malefyt, R., Coffman, R.L., and O'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683-765.
Moser, M. (2003). Dendritic cells. In Fundamental Immunology (W. E. Paul, ed) Lippincott Williams & Wilkins, Philadelphia 455-480.
Mowat, A.M. (2003). Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3, 331-341.
Murphy, K.M., and Reiner, S.L. (2002). The lineage decisions of helper T cells. Nat Rev Immunol 2, 933-944.
Muscettola, M., Massai, L., Tanganelli, C., and Grasso, G. (1994): Effects of lactobacilli on interferon production in young and aged mice. Ann N Y Acad Sci 717, 226-232.
Niers, L.E., Timmerman, H.M., Rijkers, G.T., van Bleek, G.M., van Uden, N.O., Knol, E.F., Kapsenberg, M.L., Kimpen, J.L., and Hoekstra, M.O. (2005). Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 35, 1481-1489.
O'Mahony, L., Feeney, M., O'Halloran, S., Murphy, L., Kiely, B., Fitzgibbon, J., Lee, G., O'Sullivan, G., Shanahan, F., and Collins, J.K. (2001). Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 15, 1219-1225.
Ogawa, T., Asai, Y., Tamai, R., Makimura, Y., Sakamoto, H., Hashikawa, S., and Yasuda, K. (2006). Natural killer cell activities of synbiotic Lactobacillus casei ssp. casei in conjunction with dextran. Clin Exp Immunol 143, 103-109.
Olivares, M., Diaz-Ropero, M.P., Sierra, S., Lara-Villoslada, F., Fonolla, J., Navas, M., Rodriguez, J.M., and Xaus, J. (2007). Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23, 254-260.
Otte, J.M., and Podolsky, D.K. (2004). Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 286, G613-626.
Park, J.H., Um, J.I., Lee, B.J., Goh, J.S., Park, S.Y., Kim, W.S., and Kim, P.H. (2002). Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production. Cell Immunol 219, 22-27.
Pelto, L., Isolauri, E., Lilius, E.M., Nuutila, J., and Salminen, S. (1998). Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy 28, 1474-1479.
Pena, J.A., Li, S.Y., Wilson, P.H., Thibodeau, S.A., Szary, A.J., and Versalovic, J. (2004). Genotypic and phenotypic studies of murine intestinal lactobacilli: species differences in mice with and without colitis. Appl Environ Microbial 70, 558-568.
Perdigon, G., de Macias, M.E., Alvarez, S., Oliver, G., and de Ruiz Holgado, A.P. (1988). Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 63, 17-23.
Perdigon, G., Maldonado Galdeano, C., Valdez, J.C., and Medici, M. (2002). Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 56 Suppl 4, S21-26.
Pessi, T., Sutas, Y., Hurme, M., and Isolauri, E. (2000). Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30, 1804-1808.
Pessi, T., Sutas, Y., Saxelin, M., Kallioinen, H., and Isolauri, E. (1999). Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbial 65, 4725-4728.
Pochard, P., Gosset, P., Grangette, C., Andre, C., Tonnel, A.B., Pestel, J., and Mercenier, A. (2002). Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 110, 617-623.
Pohjavuori, E., Viljanen, M., Korpela, R., Kuitunen, M., Tiittanen, M., Vaarala, O., and Savilahti, E. (2004). Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy, J Allergy Clin Immunol 114, 131-136.
Prantera, C., Scribano, M.L., Falasco, G., Andreoli, A., and Luzi, C. (2002). Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 51, 405-409.
Prioult, G., Fliss, I., and Pecquet, S. (2003). Effect of probiotic bacteria on induction and maintenance of oral tolerance to beta-lactoglobulin in gnotabiotic mice. Clin Diagn Lab Immunol 10, 787-792.
Prioult, G., Pecquet, S., and Fliss, I. (2004). Stimulation of interleukin-10 production by acidic beta-actoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases. Clin Diagn Lab Immunol 11, 266-271.
Rembacken, B.J., Snelling, A.M., Hawkey, P.M., Chalmers, D.M., and Axon, A.T. (1999). Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354, 635-639.
Rigby, R.J., Knight, S.C., Kamm, M.A., and Stagg, A.J. (2005). Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin Exp Immunol 139, 245-256.
Rosenfeldt, V., Benfeldt, E., Nielsen, S.D., Michaelsen, K.F., Jeppesen, D.L., Valerius, N.H., and Paerregaard, A. (2003). Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111, 389-395.
Ruiz, P.A., Hoffmann, M., Szcesny, S., Blaut, M., and Haller, D. (2005). Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology 115, 441-450.
Schiffrin, E.J. (1994). Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78, 491-497.
Schiffrin, E.J., Brassart, D., Servin, A.L., Rochat, F., and Donnet-Hughes, A. (1997). Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 66, 515S-520S.
Schultz, M., Timmer, A., Herfarth, H.H., Sartor, R.B., Vanderhoof, J.A., and Rath, H.C. (2004). Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterol 4, 5.
Sheih, Y.H., Chiang, B.L., Wang, L.H., Liao, C.K., and Gill, H.S. (2001). Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 20, 149-156.
Sheil, B., McCarthy, J., O'Mahony, L., Bennett, M.W., Ryan, P., Fitzgibbon, J.J., Kiely, B., Collins, J.K., and Shanahan, F. (2004). Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53, 694-700.
Shevach, E.M. (2000). Suppressor T cells: Rebirth, function and homeostasis. Curr Biol 10, R572-575.
Shida, K., Kiyoshima-Shibata, J., Nagaoka, M., Watanabe, K., and Nanno, M. (2006). Induction of interleukin-12 by lactobacillus strains having a rigid cell wall resistant to intracellular digestion. J Dairy Sci 89, 3306-3317.
Shida, K., Takahashi, R., Iwadate, E., Takamizawa, K., Yasui, H., Sato, T., Habu, S., Hachimura, S., and Kaminogawa, S. (2002). Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy 32, 563-570.
Smits, H.H., Engering, A., van der Kleij, D., de Jong, E.C., Schipper, K., van Capel, T.M., Zaat, B.A., Yazdanbakhsh, M., Wierenga, E.A., van Kooyk, Y., et al. (2005). Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 115, 1260-1267.
Strober, W., Fuss, I.J., and Blumberg, R.S. (2002). The immunology of mucosal models of inflammation. Annu Rev Immunol 20, 495-549.
Sturm, A., Rilling, K., Baumgart, D.C., Gargas, K., Abou-Ghazale, T., Raupach, B., Eckert, J., Schumann, R.R., Enders, C., Sonnenborn, U., et al. (2005). Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Infect Immun 73, 1452-1465.
Sudo, N., Sawamura, S., Tanaka, K., Aiba, Y., Kubo, C., and Koga, Y. (1997). The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159, 1739-1745.
Sutas, Y., Hurme, M., and Isolauri, E. (1996a). Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. Scand J Immunol 43, 687-689.
Sutas, Y., Soppi, E., Korhonen, H., Syvaoja, E.L., Saxelin, M., Rokka, T., and Isolauri, E. (1996b). Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes. J Allergy Clin Immunol 98, 216-224.
Takeda, K., Suzuki, T., Shimada, S.I., Shida, K., Nanno, M., and Okumura, K. (2006). Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol 146, 109-115.
Taylor, A.L., Dunstan, J.A., and Prescott, S.L. (2007). Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 119, 184-191.
Tien, M.T., Girardin, S.E., Regnault, B., Le Bourhis, L., Dillies, M.A., Coppee, J.Y., Bourdet-Sicard, R., Sansonetti, P.J., and Pedron, T. (2006). Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176, 1228-1237.
Vinderola, G Matar, C., and Perdigon, G. (2005). Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors. Clin Diagn Lab Immunol 12, 1075-1084.
von der Weid, T., Bulliard, C., and Schiffrin, E.J. (2001). Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and intedeukin-10. Clin Diagn Lab Immunol 8, 695-701.
Yan, F., and Polk, D.B. (2002). Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277, 50959-50965.
Zhang, L., Li, N., Caicedo, R., and Neu, J. (2005). Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr 135, 1752-1756.